cholestyramine resin has been researched along with insulin glargine in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (insulin glargine) | Trials (insulin glargine) | Recent Studies (post-2010) (insulin glargine) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 2,184 | 772 | 1,350 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acikgoz, SB; Kara, RO; Kosem, M; Solak, B | 1 |
1 other study(ies) available for cholestyramine resin and insulin glargine
| Article | Year |
|---|---|
First and only symptom of undiagnosed diabetes mellitus: eruptive xanthoma.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Diabetes Mellitus, Type 2; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Aspart; Insulin Glargine; Middle Aged; Skin Diseases; Xanthomatosis | 2015 |